These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1690865)

  • 21. CD4, CD8 and NK subsets in B-CLL.
    Vuillier F; Tortevoye P; Binet JL; Dighiero G
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):331-4. PubMed ID: 3265505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
    Pattengale PK; Sundstrom C; Yu AL; Levine A
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients.
    Vacher-Coponat H; Brunet C; Lyonnet L; Bonnet E; Loundou A; Sampol J; Moal V; Dussol B; Brunet P; Berland Y; Dignat-George F; Paul P
    Nephrol Dial Transplant; 2008 Apr; 23(4):1406-14. PubMed ID: 18029366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-reactive protein antigenicity on the surface of human peripheral blood lymphocytes. Characterization of lymphocytes reactive with anti-neo-CRP.
    Bray RA; Samberg NL; Gewurz H; Potempa LA; Landay AL
    J Immunol; 1988 Jun; 140(12):4271-8. PubMed ID: 2453575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients.
    Balch CM; Tilden AB; Dougherty PA; Cloud GA; Abo T
    Surgery; 1984 Jan; 95(1):63-70. PubMed ID: 6581546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mlsa generated suppressor cells. I. Suppression is mediated by double-negative (CD3+CD5+CD4-CD8-) alpha/beta T cell receptor-bearing cells.
    Bruley-Rosset M; Miconnet I; Canon C; Halle-Pannenko O
    J Immunol; 1990 Dec; 145(12):4046-52. PubMed ID: 1701781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability.
    Abo T; Cooper MD; Balch CM
    J Immunol; 1982 Oct; 129(4):1752-7. PubMed ID: 6980948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressive effect of human natural killer cells on pokeweed mitogen-induced B cell differentiation.
    Arai S; Yamamoto H; Itoh K; Kumagai K
    J Immunol; 1983 Aug; 131(2):651-7. PubMed ID: 6223088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted cytotoxic cells in human peripheral blood lymphocytes.
    Garrido MA; Perez P; Titus JA; Valdayo MJ; Winkler DF; Barbieri SA; Wunderlich JR; Segal DM
    J Immunol; 1990 Apr; 144(8):2891-8. PubMed ID: 1691221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential recognition of a BCR/ABL peptide by lymphocytes from normal donors and chronic myeloid leukemia patients.
    Bertazzoli C; Marchesi E; Passoni L; Barni R; Ravagnani F; Lombardo C; Corneo GM; Pioltelli P; Pogliani E; Gambacorti-Passerini C
    Clin Cancer Res; 2000 May; 6(5):1931-5. PubMed ID: 10815918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural killer and lymphokine-activated killer cell functions in chronic myeloid leukemia.
    Rajaram N; Tatake RJ; Advani SH; Naik SL; Gangal SG
    Cancer Immunol Immunother; 1990; 31(1):44-8. PubMed ID: 2306755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased natural killer cells and decreased CD3(+)CD8(+)CD62L(+) T cells in CML patients who sustained complete molecular remission after discontinuation of imatinib.
    Ohyashiki K; Katagiri S; Tauchi T; Ohyashiki JH; Maeda Y; Matsumura I; Kyo T
    Br J Haematol; 2012 Apr; 157(2):254-6. PubMed ID: 22077498
    [No Abstract]   [Full Text] [Related]  

  • 34. Natural and antibody-dependent cellular cytotoxicity in chronic myeloid leukemia patients in remission.
    Dabholkar M; Advani S; Tatake R; Gangal S
    Leuk Res; 1986; 10(2):203-9. PubMed ID: 3456474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis.
    Pierson BA; Miller JS
    Blood; 1996 Sep; 88(6):2279-87. PubMed ID: 8822949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural killer (NK) cell immunodeficiency in patients with chronic myelogenous leukemia. II. Successful cloning and amplification of natural killer cells.
    Fujimiya Y; Chang WC; Bakke A; Horwitz D; Pattengale PK
    Cancer Immunol Immunother; 1987; 24(3):213-20. PubMed ID: 3496152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural killer cells in chronic leukemia. Function and markers.
    Sørskaar D; Førre O; Stavem P
    Int Arch Allergy Appl Immunol; 1988; 87(2):159-64. PubMed ID: 2973442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. III. Defective interleukin-2 production by T-helper and natural killer cells.
    Chang WC; Fujimiya Y; Casteel N; Pattengale P
    Int J Cancer; 1989 Apr; 43(4):591-7. PubMed ID: 2522912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of natural killer cells in the treatment of chronic myeloid leukemia.
    Silla LM; Whiteside TL; Ball ED
    J Hematother; 1995 Aug; 4(4):269-79. PubMed ID: 7489141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophages protect mycoplasma-infected chronic myeloid leukemia cells from natural killer cell killing.
    Choo QWW; Koean RAG; Chang SC; Chng WJ; Chan MC; Wang W; Er JZ; Ding JL
    Immunol Cell Biol; 2020 Feb; 98(2):138-151. PubMed ID: 31837284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.